The dilution for equity requirements is exactly what I was pondering today. This scenario seems to me to be the most reasonable scenario that answers the questions, "why is the company so quiet and why is there so much dilution with no updates?" I think the puzzle pieces fit best with this scenario. All IMO.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links